Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDM2005 + SOC in Diffuse Large B-Cell Lymphoma (DLBCL)
NCT07124936Phase 2Recruiting
- Sponsor
- Huadong Medicine
- Start
- Jul 2025
- Primary completion
- Oct 2027
- Modality
- Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of HDM2005 in diffuse large B-cell lymphoma (DLBCL), sponsored by Huadong Medicine. Started Jul 2025; status: recruiting.
02
Drugs
HDM2005
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT07124936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07124936.